Gemcitabine


Gemcitabine (pronunciation: jem-SITE-a-been) is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company.
It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.